Sign up to our newsletter Subscribe
Challenges and Solutions for Budget Impact Analysis of Gene Therapies

Sign up to our newsletter Subscribe
Mata Charokopou, PharmD, MSc, Senior Director – Head of Global Payer Strategy & Health Economics in UCB. She is responsible for the development of evidence generation strategies, patient value strategy across portfolio and engagement with payers to ensure patient’s access to the right healthcare solutions. Charokopou has challenged the status quo of economic modelling practices to integrate patient value elements that are not being captured by existing payer value frameworks. Charokopou graduated from the University of Patras, Greece, in 2010, with a PharmD in Pharmacy and she received a Master of Science in Health Economics, Policy and Law from the Erasmus University of Rotterdam, Netherlands, in 2011.
An error has occurred, please try again later.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!